Citigroup’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Other funds holding BME
NRW
NRI
Citigroup's BME Position: Q4 2021 in Review
Citigroup sold out of BlackRock Health Sciences Trust (BME) in Q4 2021, closing a stake of 588 shares — an estimated $28K sold.
Citigroup first reported a position in BME in Q2 2013 and held it in 23 quarters. The position peaked at $106K in Q3 2013. 60 funds tracked by Wall St. Rank hold BME as of Q4 2021.
- Citigroup reported no remaining BlackRock Health Sciences Trust position as of Q4 2021 after selling out during the quarter.
- Citigroup sold 588 BlackRock Health Sciences Trust shares in Q4 2021, an estimated $28K.
- Citigroup first reported a position in BlackRock Health Sciences Trust in Q2 2013 and held it in 23 quarters.
- Citigroup's BlackRock Health Sciences Trust position peaked at $106K in Q3 2013.
- 60 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2021.
Based on Citigroup's 13F filing for Q4 2021, filed 10 Feb 2022.